← Leaderboards
Todd M Allen
Massachusetts General Hospital
$28,600,717
Attributed
$31,823,721
Total exposure
20
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.3M · FY2005–23$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$48,246,239 · 22
By mechanism
P01$26,723,560 · 9
R01$10,572,223 · 4
U19$5,308,810 · 4
U24$3,279,412 · 1
R37$960,269 · 1
R21$959,673 · 2
Top collaborators
- Eric Hunter5 shared
- Marcus Altfeld2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Georg Michael Lauer$24,583,765
- Marcus Altfeld$19,256,149
- Bruce D Walker$50,324,331
- Boris Dominik Juelg$12,991,342
- Lynn T Matthews$9,738,295
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralInfectionResponseT-LymphocyteImmuneVirusImmune ResponseCellsCd8b1 GeneHiv InfectionsVariantVaccinesMutationEpitopesT Cell ResponseEvolutionFitnessPreventMouse ModelDesignVaccine DesignTransmission ProcessAllelesAcute
Grant awards (83)
Development of Allogeneic CAR T Cell Therapy for a Functional Cure of HIV Infection$471,626
R37 · FY2023 · AI · contact PI
Virologic Correlates of Heterosexual Transmission$1,166,079
R01 · FY2022 · AI
Development of Allogeneic CAR T Cell Therapy for a Functional Cure of HIV Infection$488,643
R37 · FY2022 · AI · contact PI
HCV Ghost Sequencing Center$162,562
U24 · FY2022 · DA · contact PI
Virologic Correlates of Heterosexual Transmission$1,178,079
R01 · FY2021 · AI
Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak Investigation$632,656
U24 · FY2021 · DA · contact PI
Virologic Correlates of Heterosexual Transmission$1,181,079
R01 · FY2020 · AI
Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak Investigation$632,656
U24 · FY2020 · DA · contact PI
Virologic Correlates of Heterosexual Transmission$1,251,504
R01 · FY2019 · AI
Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak Investigation$632,656
U24 · FY2019 · DA · contact PI
Leveraging Genetic Engineering Towards a Functional Cure of HIV Infection$336,362
U19 · FY2019 · HL · contact PI
Virologic Correlates of Heterosexual Transmission$1,185,704
R01 · FY2018 · AI
Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak Investigation$595,373
U24 · FY2018 · DA · contact PI
Leveraging Genetic Engineering Towards a Functional Cure of HIV Infection$434,857
U19 · FY2018 · HL · contact PI
Virology Core$106,547
U19 · FY2018 · AI · contact PI
Optimizing Human B and T Cell Vaccines Against HIV Using Humanized BLT Mice$2,454,595
P01 · FY2017 · AI · contact PI
Animal and Laboratory Core$818,828
P01 · FY2017 · AI · contact PI
Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak Investigation$623,509
U24 · FY2017 · DA · contact PI
Optimizing CD8+ T Cell Vaccine Responses Against HIV$476,417
P01 · FY2017 · AI · contact PI
Leveraging Genetic Engineering Towards a Functional Cure of HIV Infection$434,857
U19 · FY2017 · HL · contact PI
Administrative and Biostatistics Core$207,410
P01 · FY2017 · AI · contact PI
Virology Core$90,769
U19 · FY2017 · AI · contact PI
Optimizing Human B and T Cell Vaccines Against HIV Using Humanized BLT Mice$2,458,248
P01 · FY2016 · AI · contact PI
Animal and Laboratory Core$667,106
P01 · FY2016 · AI · contact PI
Leveraging Genetic Engineering Towards a Functional Cure of HIV Infection$434,857
U19 · FY2016 · HL · contact PI
Optimizing CD8+ T Cell Vaccine Responses Against HIV$384,307
P01 · FY2016 · AI · contact PI
Administrative and Biostatistics Core$170,277
P01 · FY2016 · AI · contact PI
Virology Core$80,148
U19 · FY2016 · AI · contact PI
Optimizing Human B and T Cell Vaccines Against HIV Using Humanized BLT Mice$2,461,800
P01 · FY2015 · AI · contact PI
Animal and Laboratory Core$645,312
P01 · FY2015 · AI · contact PI
Leveraging Genetic Engineering Towards a Functional Cure of HIV Infection$452,107
U19 · FY2015 · HL · contact PI
Optimizing CD8+ T Cell Vaccine Responses Against HIV$385,853
P01 · FY2015 · AI · contact PI
Administrative and Biostatistics Core$157,227
P01 · FY2015 · AI · contact PI
Virology Core$106,547
U19 · FY2015 · AI · contact PI
Optimizing Human B and T Cell Vaccines Against HIV Using Humanized BLT Mice$2,465,248
P01 · FY2014 · AI · contact PI
Animal and Laboratory Core$728,637
P01 · FY2014 · AI · contact PI
Optimizing CD8+ T Cell Vaccine Responses Against HIV$393,756
P01 · FY2014 · AI · contact PI
Administrative and Biostatistics Core$160,447
P01 · FY2014 · AI · contact PI
Virology Core$84,859
U19 · FY2014 · AI · contact PI
Optimizing Human B and T Cell Vaccines Against HIV Using Humanized BLT Mice$2,500,944
P01 · FY2013 · AI · contact PI
Acute HIV Infection: Implications for vaccine design$1,715,563
P01 · FY2013 · AI · contact PI
Animal and Laboratory Core$791,002
P01 · FY2013 · AI · contact PI
Protective Role of Subdominant Responses to HIV Restricted by Common HLA Alleles$480,286
R01 · FY2013 · AI · contact PI
Optimizing CD8+ T Cell Vaccine Responses Against HIV$402,020
P01 · FY2013 · AI · contact PI
Impact of CTL Escape Mutations on HCV Replicative Fitness$274,331
U19 · FY2013 · AI · contact PI
Administrative and Biostatistics Core$170,122
P01 · FY2013 · AI · contact PI
Acute HIV Infection: Implications for vaccine design$2,366,120
P01 · FY2012 · AI · contact PI
Protective Role of Subdominant Responses to HIV Restricted by Common HLA Alleles$436,795
R01 · FY2012 · AI · contact PI
HIV Sequencing Core$334,321
P01 · FY2012 · AI · contact PI
Impact of CTL Escape Mutations on HCV Replicative Fitness$291,835
U19 · FY2012 · AI · contact PI
Identifying Acute Phase CTL Escape Mutations and their Impact on HIV Fitness$230,665
P01 · FY2012 · AI · contact PI
HIV Sequencing Core$711,099
P01 · FY2011 · AI · contact PI
Identifying Acute Phase CTL Escape Mutations and their Impact on HIV Fitness$489,082
P01 · FY2011 · AI · contact PI
Protective Role of Subdominant Responses to HIV Restricted by Common HLA Alleles$436,831
R01 · FY2011 · AI · contact PI
Impact of CTL Escape Mutations on HCV Replicative Fitness$347,454
U19 · FY2011 · AI · contact PI
Protective Role of Subdominant Responses to HIV Restricted by Common HLA Alleles$441,280
R01 · FY2010 · AI · contact PI
HIV Sequencing Core$437,143
P01 · FY2010 · AI · contact PI
Impact of CTL Escape Mutations on HCV Replicative Fitness$360,788
U19 · FY2010 · AI · contact PI
Identifying Acute Phase CTL Escape Mutations and their Impact on HIV Fitness$298,990
P01 · FY2010 · AI · contact PI
Impact of CTL Escape Mutations on HIV-1 Replicative Fitness$442,292
R56 · FY2009 · AI · contact PI
HIV Sequencing Core$382,638
P01 · FY2009 · AI · contact PI
Impact of CTL Escape Mutations on HCV Replicative Fitness$374,864
U19 · FY2009 · AI · contact PI
Identifying Acute Phase CTL Escape Mutations and their Impact on HIV Fitness$260,181
P01 · FY2009 · AI · contact PI
CD8 T Cell Seletive Pressure and Hepatitis C Virus Sequence Evolution$257,927
U19 · FY2009 · AI · contact PI
Impact of NK Cell Immune Pressures on HCV Evolution and Viral Fitness$220,313
R21 · FY2009 · AI
CD8 T Cell Selective Pressure and HCV Sequence Evolution$193,597
R01 · FY2009 · AI · contact PI
HIV Sequencing Core$334,609
P01 · FY2008 · AI · contact PI
Identifying Acute Phase CTL Escape Mutations and their Impact on HIV Fitness$263,593
P01 · FY2008 · AI · contact PI
Impact of NK Cell Immune Pressures on HCV Evolution and Viral Fitness$263,250
R21 · FY2008 · AI
CD8 T Cell Seletive Pressure and Hepatitis C Virus Sequence Evolution$252,306
U19 · FY2008 · AI · contact PI
CD8 T Cell Selective Pressure and HCV Sequence Evolution$169,784
R01 · FY2008 · AI · contact PI
Acute CTL Escape and Viral Variation in HIV$410,088
R01 · FY2007 · AI · contact PI
CD8 T Cell Seletive Pressure and Hepatitis C Virus Sequence Evolution$201,285
U19 · FY2007 · AI · contact PI
CD8 T Cell Selective Pressure and HCV Sequence Evolution$173,072
R01 · FY2007 · AI · contact PI
Acute CTL Escape and Viral Variation in HIV$422,336
R01 · FY2006 · AI · contact PI
Impact of CD8 Escape Mutations on Capsid Structure/Host$213,610
R21 · FY2006 · AI · contact PI
CD8 T Cell Seletive Pressure and HCV Sequence Evolution$192,162
U19 · FY2006 · AI · contact PI
CD8 T Cell Selective Pressure and HCV Sequence Evolution$175,000
R01 · FY2006 · AI · contact PI
Acute CTL Escape and Viral Variation in HIV$432,500
R01 · FY2005 · AI
Impact of CD8 Escape Mutations on Capsid Structure/Host$262,500
R21 · FY2005 · AI
CD8 T Cell Seletive Pressure and HCV Sequence Evolution$193,948
U19 · FY2005 · AI
Acute CTL Escape and Viral Variation in HIV$432,500
R01 · FY2004 · AI
Acute CTL Escape and Viral Variation in HIV$405,709
R01 · FY2003 · AI